Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 6, 2026

Nov. 6, 2026

The Cancer Gene Therapy Market Is Projected to Reach $8.9 Billion by 2030 Driven by Robust Industry Expansion

Indeterminate EIN Presswire

Nov. 6, 2026

Calciphylaxis Treatment Market Projected to Grow Rapidly at an 8.3% CAGR Through 2030

Indeterminate EIN Presswire

Nov. 6, 2026

Conservation Visions and FACE Join Forces to Advance Wild Harvest Research Across Europe

Indeterminate EIN Presswire

Nov. 6, 2026

Ultrafast All‑Optical Biomimetic Encoder Unlocks Neuromorphic Computing Over Fiber Networks

Indeterminate EIN Presswire

Nov. 6, 2026

Biofrontera Inc. to Report Third Quarter 2026 Financial Results on November 13, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

MediPharm Labs Sets Date to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 6, 2026

Confluent Medical Technologies Acquires Northern Nitinol, Expanding Advanced Nitinol Rapid Prototyping Capabilities

Indeterminate GlobeNewswire

Nov. 6, 2026

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire

Nov. 6, 2026

Sanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 6, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Anywhere Active Launches Virtual Fitness Platform for Public Libraries and Community Organizations

Indeterminate GlobeNewswire

Nov. 6, 2026

Entera Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 6, 2026

Amwell makes grant to new employees under inducement plan

Indeterminate GlobeNewswire

Nov. 6, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Nov. 6, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 6, 2026

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 6, 2026

LeMaitre to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 6, 2026

National Tirzepatide Online Telehealth Provider Ozari Health Launches Ozari Select Monthly Plan in All 50 States

Indeterminate GlobeNewswire